In the last trading session, 1.6 million TELA Bio Inc (NASDAQ:TELA) shares changed hands as the company’s beta touched 0.64. With the company’s per share price at $1.08 changed hands at -$0.09 or -7.69% during last session, the market valuation stood at $42.72M. TELA’s last price was a discount, traded about -501.85% off its 52-week high of $6.50. The share price had its 52-week low at $1.14, which suggests the last value was -5.56% down since then. When we look at TELA Bio Inc’s average trading volume, we note the 10-day average is 0.62 million shares, with the 3-month average coming to 254.50K.
Analysts gave the TELA Bio Inc (TELA) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.40. If we narrow down to specifics, the data shows that 0 out of 2 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended TELA as a Hold, 2 felt it is a Buy and 0 rated the stock as Underweight. TELA Bio Inc’s EPS for the current quarter is expected to be -0.21.
TELA Bio Inc (NASDAQ:TELA) trade information
Instantly TELA was in red as seen at the end of in last trading. With action -12.55%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -64.24%, with the 5-day performance at -12.55% in the red. However, in the 30-day time frame, TELA Bio Inc (NASDAQ:TELA) is -55.56% down. Looking at the short shares, we see there were 0.45 million shares sold at short interest cover period of 2.8 days.
The consensus price target for the stock as assigned by Wall Street analysts is 11, meaning bulls need an upside of 90.18% from its current market value. According to analyst projections, TELA’s forecast low is 8 with 20 as the target high. To hit the forecast high, the stock’s price needs a -1751.85% plunge from its current level, while the stock would need to soar -640.74% for it to hit the projected low.
TELA Bio Inc (TELA) estimates and forecasts
Year-over-year growth is forecast to reach 23.51% up from the last financial year.
Consensus estimates given by 5 financial analysts project the company’s revenue in the current quarter to hit an average of 17.37M. 5 analysts are of the opinion that TELA Bio Inc’s revenue for the current quarter will be 21M. The company’s revenue for the corresponding quarters a year ago was 16.6M and 16.09M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 4.59%. The estimates for the next quarter sales put growth at 30.53%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 12.91%. The 2025 estimates are for TELA Bio Inc earnings to increase by 51.13%.
TELA Dividends
TELA Bio Inc is expected to release its next quarterly earnings report on 2025-Mar-19.
TELA Bio Inc (NASDAQ:TELA)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.40% of TELA Bio Inc shares while 72.47% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 79.12%. There are 72.47% institutions holding the TELA Bio Inc stock share, with ESSEX WOODLANDS MANAGEMENT, INC. the top institutional holder. As of 2024-06-30, the company held 16.6674% of the shares, roughly 4.11 million TELA shares worth $19.32 million.
ORBIMED ADVISORS LLC holds the second largest percentage of outstanding shares, with 9.9644% or 2.46 million shares worth $11.55 million as of 2024-06-30.
